肝门部胆管癌的外科治疗  

Surgical treatment for hilar cholangiocarcinoma

作　　者：刘召波[1] 卢实春[1] 李宁[1] 林栋栋[1] 赖威[1] 王孟龙[1] 武聚山[1] 郭庆良[1] 

机构地区：[1]首都医科大学附属北京佑安医院肝胆外科暨肝移植中心,100069

出　　处：《中华消化外科杂志》2013年第3期186-190,共5页Chinese Journal of Digestive Surgery

基　　金：北京市卫生系统高层次卫生技术人才培养计划（2011-2-18）;北京市教育委员会科技计划（KM201110025026）;首都卫生发展科研专项（2011-2018-03）

摘　　要：肝门部胆管癌切除率低，预后差。近年来随着高分辨率影像学技术的应用、手术器械的改进、围手术期治疗策略的优化，特别是手术技巧的改进和经验的积累，使肝门部胆管癌切除率及根治率得到大幅度的提高。手术切除是治疗肝门部胆管癌的主要手段，根治性切除仍然是患者获得长期生存甚至治愈最重要的措施。本文回顾性分析2004年4月至2012年4月首都医科大学附属北京佑安医院收治的66例肝门部胆管癌患者的临床资料，探讨肝门部胆管癌外科治疗中的关键技术及相关预后。Hilar cholangiocarcinoma （HCC） is a rare tumor with a poor prognosis. With the development of high defi- nition imaging technology, improvement of surgical instruments, optimization of perioperative surgical strategies and accumulation of surgical experiences, the radical resection rate of HCC is sig- nificantly improved. Operation is the main method of treatment for HCC, and radical resection is important for a long-term sur- vival of HCC patients. The clinical data of 66 patients with HCC who were admitted to the Beijing Youan Hospital from April 2004 to April 2012 were retrospectively analyzed. The key points in surgical procedure and prognosis of oatients were investigated.

关 键 词：胆管肿瘤 肝门 外科手术 

分 类 号：R735.8[医药卫生—肿瘤]